Nature reviews. Gastroenterology & hepatology
Nivolumab and ipilimumab as neoadjuvant therapy for potentially resectable HCC.
Jordan Hindson
Published: 202510.1038/s41575-025-01136-x
No abstract available for this study.
Jordan Hindson
No abstract available for this study.